171 related articles for article (PubMed ID: 21218508)
1. Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia.
Matafome P; Louro T; Rodrigues L; Crisóstomo J; Nunes E; Amaral C; Monteiro P; Cipriano A; Seiça R
Diabetes Metab Res Rev; 2011 Jan; 27(1):54-62. PubMed ID: 21218508
[TBL] [Abstract][Full Text] [Related]
2. A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.
Matafome P; Nunes E; Louro T; Amaral C; Crisóstomo J; Rodrigues L; Moedas AR; Monteiro P; Cipriano A; Seiça R
Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):241-51. PubMed ID: 18936912
[TBL] [Abstract][Full Text] [Related]
3. The combined effect of metformin and L-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats.
Salman ZK; Refaat R; Selima E; El Sarha A; Ismail MA
Eur J Pharmacol; 2013 Aug; 714(1-3):448-55. PubMed ID: 23845213
[TBL] [Abstract][Full Text] [Related]
4. Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus.
Riad A; Du J; Stiehl S; Westermann D; Mohr Z; Sobirey M; Doehner W; Adams V; Pauschinger M; Schultheiss HP; Tschöpe C
Eur J Pharmacol; 2007 Aug; 569(3):204-11. PubMed ID: 17669395
[TBL] [Abstract][Full Text] [Related]
5. Insulin and metformin may prevent renal injury in young type 2 diabetic Goto-Kakizaki rats.
Louro TM; Matafome PN; Nunes EC; da Cunha FX; Seiça RM
Eur J Pharmacol; 2011 Feb; 653(1-3):89-94. PubMed ID: 21167150
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP
J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin-mediated protection of the retina in a model of diabetes with hyperlipidemia.
Fernandes R; Bento CF; Matafome P; Sena CM; Seiça RM; Pereira P
Can J Physiol Pharmacol; 2014 Dec; 92(12):1037-43. PubMed ID: 25404034
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic association of atorvastatin and insulin in cardiac ischemia: study in a model of type 2 diabetes with hyperlipidemia.
Matafome P; Monteiro P; Nunes E; Louro T; Amaral C; Moedas AR; Gonçalves L; Providência L; Seiça R
Pharmacol Res; 2008; 58(3-4):208-14. PubMed ID: 18692137
[TBL] [Abstract][Full Text] [Related]
9. Promising role of ferulic acid, atorvastatin and their combination in ameliorating high fat diet-induced stress in mice.
Kesh SB; Sikder K; Manna K; Das DK; Khan A; Das N; Dey S
Life Sci; 2013 May; 92(17-19):938-49. PubMed ID: 23567805
[TBL] [Abstract][Full Text] [Related]
10. Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers.
Abdin AA; Baalash AA; Hamooda HE
J Diabetes Complications; 2010; 24(3):168-78. PubMed ID: 19328014
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of atorvastatin and metformin on glucose-induced variations of inflammatory process in patients with diabetes mellitus.
Tousoulis D; Koniari K; Antoniades C; Papageorgiou N; Miliou A; Noutsou M; Nikolopoulou A; Marinou K; Stefanadi E; Siasos G; Charakida M; Kamboli AM; Stefanadis C
Int J Cardiol; 2011 May; 149(1):46-9. PubMed ID: 20034685
[TBL] [Abstract][Full Text] [Related]
13. Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens.
Martín-Castillo A; Castells MT; Adánez G; Polo MT; Pérez BG; Ayala I
Biomed Pharmacother; 2010 Apr; 64(4):275-81. PubMed ID: 19932590
[TBL] [Abstract][Full Text] [Related]
14. Effects of guggulsterone isolated from Commiphora mukul in high fat diet induced diabetic rats.
Sharma B; Salunke R; Srivastava S; Majumder C; Roy P
Food Chem Toxicol; 2009 Oct; 47(10):2631-9. PubMed ID: 19635521
[TBL] [Abstract][Full Text] [Related]
15. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties.
Momi S; Impagnatiello F; Guzzetta M; Caracchini R; Guglielmini G; Olivieri R; Monopoli A; Gresele P
Eur J Pharmacol; 2007 Sep; 570(1-3):115-24. PubMed ID: 17632098
[TBL] [Abstract][Full Text] [Related]
16. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
[TBL] [Abstract][Full Text] [Related]
17. Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells.
Kim DS; Jeong SK; Kim HR; Kim DS; Chae SW; Chae HJ
Immunopharmacol Immunotoxicol; 2010 Jun; 32(2):251-7. PubMed ID: 20038265
[TBL] [Abstract][Full Text] [Related]
18. Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
Chu CS; Lee KT; Lee MY; Su HM; Voon WC; Sheu SH; Lai WT
Am J Cardiol; 2006 Mar; 97(5):646-50. PubMed ID: 16490430
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin: in the management of hyperlipidaemia.
Ray SK; Rege NN
J Postgrad Med; 2000; 46(3):242-3. PubMed ID: 11298482
[No Abstract] [Full Text] [Related]
20. Influence of atorvastatin on the pharmacokinetics and pharmacodynamics of glyburide in normal and diabetic rats.
Neerati P; Gade J
Eur J Pharm Sci; 2011 Feb; 42(3):285-9. PubMed ID: 21182938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
